Image Credit: Canva
A condition, known commonly as "black urine disease" or Alkaptonuria is a rare genetic disorder involving protein metabolism, and it has its root in the mutation of the homogentisate 1,2-dioxygenase gene, which in turn causes homogentisic acid accumulation in the body. The appearance of dark urine after exposure to air is due to this kind of accumulation; however, a variety of symptoms can be expected, such as joint stiffness, changes in pigmentation, and other long-term health complications. Although the prevalence has been estimated to be between 1 in 250,000 and 1 in 1 million people in the United States, its effects are indeed high on those affected.
Alkaptonuria is an autosomal recessive disease, meaning that the child must inherit a defective copy of the HGD gene from both parents. If both parents are carriers, their offspring have a 25% chance of inheriting two faulty genes and developing alkaptonuria. The condition is genetic but is often not diagnosed for years because it progresses slowly and its early symptoms appear to be harmless.
The most characteristic and common initial symptom of alkaptonuria is dark urine. The reason for this is due to the fact that excess HGA is excreted in the urine and upon oxidation in the presence of air, it gives the urine a brown or black color. Though it is often considered cosmetic, the long-term accumulation of HGA within the connective tissues produces more complicated health problems.
Progressive joint pain and stiffness: The accumulation of HGA in cartilage leads to early-onset osteoarthritis, making movement increasingly difficult over time.
Skin and eye pigmentation changes: Affected individuals may develop bluish or grayish discoloration of the sclera (white part of the eye) and the skin, particularly in areas exposed to friction.
Cardiovascular and respiratory problems: With age, HGA accumulation can lead to valve calcifications in the heart and stiffening of connective tissues in the respiratory tract, which can cause problems in middle and old age.
Decreased mobility and spinal problems: The spine may become stiff and painful due to chronic cartilage degeneration.
These symptoms usually begin to manifest during adulthood, leading to severe complications in a person's 40s or 50s and significantly affecting the quality of their life.
Because of its rarity, alkaptonuria is often mistaken or overlooked early in life. However, there are several ways to confirm the condition:
Urine Testing: The gold standard in the diagnosis is the testing of urine samples for high levels of homogentisic acid via gas chromatography. In case of oxidation, which changes the color of urine to black, it is indicative of alkaptonuria.
Genetic Testing: Confirmatory genetic testing reveals mutations of the HGD gene to diagnose the condition conclusively.
Blood Tests: High levels of HGA in the blood can be used as further evidence.
Imaging Studies: X-rays and MRIs will expose cartilage and joint damage characteristic of alkaptonuria.
At present, there is no cure for alkaptonuria; however, various treatment approaches can reduce its symptoms and slow the disease's progress:
Nitisinone Therapy: Nitisinone is a drug that inhibits the production of HGA. It has been shown to reduce HGA levels and slow tissue damage. However, it needs to be taken under close medical supervision because of potential side effects.
Low-Protein Diet: Since HGA is a byproduct of protein metabolism, reducing protein intake—especially foods rich in tyrosine and phenylalanine—may help decrease HGA production.
Pain Management: OTC pain relievers and anti-inflammatory medications can be used to relieve joint pain and stiffness.
Physical Therapy: Exercise regularly, as it may improve mobility and strengthen muscles, thus reducing strain on affected joints.
Surgical Interventions: Most people with alkaptonuria develop severe osteoarthritis necessitating joint replacement in their old age. Also, some may require heart valve replacement surgery if cardiovascular complications develop.
Although alkaptonuria is not fatal, it severely affects the quality of life. The progressive deterioration of the joints and associated symptoms can make everyday activities difficult, requiring lifestyle changes and medical interventions. The disease may cause premature aging of the joints, requiring walking aids and mobility assistance earlier than expected.
Ongoing research will continue to work on improving the treatment options by focusing on gene therapy and alternative enzyme replacement therapies. However, because of its rarity, the clinical trials and research remain sparse.
As genetic research advances, more hope for better management and possible curative approaches for alkaptonuria exists. Scientists are searching extensively for enzyme replacement therapies and innovative drugs that can target the root cause of the disorder. Being aware and being diagnosed early helps individuals better their condition and ultimately have better long-term health outcomes.
Alkaptonuria is a striking example of how one gene mutation can have widespread effects on the body. Though still a rare and often misunderstood condition, growing awareness and advances in treatment are paving the way for better care. If you or a loved one suspect symptoms of alkaptonuria, it is essential to seek early diagnosis and medical guidance to manage the disease effectively and preserve quality of life.
Credit: iStock
Heart diseases are viewed as a universal health concern, and advancements in cardiology have hugely improved diagnosis and treatment outcomes around the world. At the same time, emerging research is shedding more light on how cardiovascular disease affects women.
In India, this perspective is especially important. Of the more than 10 million deaths recorded annually in the country, nearly two million are attributed to diseases of the circulatory system, with women accounting for about 40% of these cases. Significantly, more than half of the nearly 800,000 cardiovascular deaths among Indian women each year occur prematurely, underscoring the importance of greater awareness, early detection, and timely medical care.
It is evident that modern cardiology has been shaped by the findings from large, well-characterized populations of patients. The frameworks that have been established from such findings are the ones that guide the approaches that are currently used in the diagnosis and treatment of various forms of heart disease.
Such frameworks have been instrumental in the advancement of the management of various forms of cardiovascular diseases worldwide. As the research expands to include larger populations, there is an increased understanding that the manifestation of cardiovascular diseases differs from one group to another, particularly in females.
This growing awareness is particularly useful in recognizing symptoms. Although women, like men, may experience chest pain as a symptom of a heart attack, there are other, less common symptoms that women may also experience.
These include fatigue, shortness of breath, nausea, dizziness, as well as neck, jaw, or back discomfort. The awareness of these symptoms will allow women to seek treatment sooner, as well as help healthcare providers better understand their symptoms.
Women’s heart health is influenced by various life stages and the hormonal changes that accompany them. For instance, after menopause, estrogen levels decline, and since this hormone offers some protective benefits for the heart, the risk of developing heart disease may gradually rise.
Certain pregnancy-related conditions, including gestational diabetes, preeclampsia, and high blood pressure during pregnancy, may also indicate a greater likelihood of cardiovascular disease later in life. Recognising these factors allows doctors to monitor heart health more closely and recommend preventive measures that support long-term wellbeing.
Prevention continues to be one of the most effective strategies for reducing heart disease. Regular health check-ups, along with monitoring blood pressure, cholesterol, and blood sugar, are essential for lowering cardiovascular risk. Adopting healthy lifestyle habits further supports long-term heart health. Awareness is equally important.
Symptoms such as fatigue or breathlessness are not always immediately linked to heart disease, particularly among women. Raising awareness about heart health can help people recognize early warning signs sooner and seek timely care.
Encouragingly, the field of cardiology is constantly evolving with the help of emerging research that is further enlightening us about the health of the heart in both men and women. With more women being included in research and better developments in diagnostic procedures, healthcare professionals are refining their strategies to deal with heart health.
Thus, by adopting the best strategies and emerging research about the health of women’s hearts, awareness and early intervention are the keys to better outcomes and reduced risks among women in India.
Credit: iStock
Physical activity is a known factor for better physical and mental well-being. However, imagine severe heat forcing you to remain indoors and not being able to just walk around your neighborhood.
The new study published in the journal The Lancet Global Health predicts that by 2050, the rising temperatures are likely to stop people from being active.
It showed that lack of physical activity, especially for people unable to access gyms, will lead to an estimated 700,000 additional premature deaths.
It is also projected to cause $2.59 billion in annual productivity losses.
“Rising temperatures are projected to increase the prevalence of physical inactivity, translating into additional premature deaths and productivity losses, especially in tropical regions,” said a team of Latin American researchers, led by Pontifical Catholic University of Argentina.
The latest report comes amid climate scientists from the UN Intergovernmental Panel on Climate Change warning of a warmer climate -- between 2.7 and 3.1 degrees Celsius by 2100.
In addition, physical inactivity is already a major global health problem, with about one in three adults failing to meet World Health Organization guidelines for weekly exercise.
The study models how rising temperatures may affect physical activity globally up to the year 2050 based on an analysis of data from 156 countries between 2000 and 2022.
It suggests that by 2050, an average temperature above 27.8°C per month would increase physical inactivity by
“This translates to a predicted 0.47–0.70 million additional premature deaths annually and $2.40–3.68 billion in productivity losses,” the researchers said.
The biggest increase in inactivity will be in hotter regions such as
Heat can discourage the most common exercise regimen – walks, lead author Christian Garcia-Witulski, Professor at the Pontifical Catholic University, was quoted as saying to The Washington Post.
“The real-world picture is usually not that people suddenly stop moving altogether. It is that heat that gradually erodes the safe, comfortable, and practical opportunities people have to stay active in everyday life,” Garcia-Witulski said.
Regular physical activity promotes both mental and physical health in people of all ages. The WHO advises at least 150 minutes of moderate or 75 minutes of vigorous exercise weekly, alongside regular muscle-strengthening activities.
As per the Global Status Report on Physical Activity 2022, more than 80 percent of adolescents and 27 percent of adults do not meet the WHO’s recommended levels of physical activity.
The UN health body also aims to achieve the global target of a 15 percent relative reduction in the prevalence of physical inactivity by 2030.
The WHO recommends that countries increase levels of physical activitywithin their populations by developing and implementing dedicated comprehensive national policies to ensure safer roads for cycling and walking, accessible opportunities for active recreation where people live, work, and play, and promoting physical activity.
The Lancet researchers called for
Credits: Canva
Meningitis outbreak has led to authorities in the UK to urge students to get vaccines and antibiotics. Health and Me also reported on the menB vaccine that students 5,000 students in Kent University will be receiving. One of the common symptoms are rashes, however, how does one know if it is a meningitis rash?

As per NHS UK, the rash appears as small, red pinpricks that could turn into red or purple blotches. This rash also does not always appear, this could be a sign of blood poisoning that is caused by meningitis.
The red dots also do not fade when you press the side of a clear glass firmly against the skin. NHS UK notes that anyone with dark skin must check for paler areas, like palms of hands or soles of feet. One much also look at the roof of the mouth or inside of the eyelids.
NHS UK notes that one must call 999, if they find such a rash.
A meningitis outbreak in Kent University is now treated as a national incident, after two people have died, one of them being the student of the university. Students have been urged to get vaccines and take antibiotics as health officials are dealing with the "unprecedented" and "explosive" outbreak.
As per the UK Health Security Agency (UKHSA), 15 cases have been reported and all of them have lead to hospital admission. Cases are also expected to rise due to the incubation period of infection to when the symptoms start to appear. The incubation period is from two to 14 days.
As per experts, many of whom are affected had attended Club Chemistry in Cantebury between 5 to 7 March. UKHSA chief executive Susan Hopkins said the outbreak "looks like a super-spreader" event with "ongoing spread" through universities' halls of residence. She added: "There will have been some parties particularly around this, so there will have been lots of social mixing. I can't yet say where the initial infection came from, how it's got into this cohort, and why it's created such an explosive amount of infections."
She further said that in her 35 years working in medicine, healthcare, and hospitals, "This is the most cases I've ever seen in a single weekend with this type of infection". She added: "It is the explosive nature that is unprecedented here - the number of cases in such a short space of time." She also remarked that this was the "quickest-growing outbreak" she has ever seen in her career.
As per the University of Oxford, MenB vaccine is given to babies at 8 weeks, 16 weeks, and one year of age.
General Practitioner surgery or clinic also send an appointment for babies to have their MenB vaccination along with their other routine vaccinations.
Read: Meningitis Outbreak: What Is MenB Vaccine?
Additional doses of the vaccine are recommended for people with some long-term health conditions who are at greater risk of more severe meningococcal disease. This includes people with:
© 2024 Bennett, Coleman & Company Limited